DXR - Daxor Corporation

NYSE American - NYSE American Delayed Price. Currency in USD

Daxor Corporation

Empire State Building
Suite 7120 350 Fifth Avenue
New York, NY 10118
United States
212-330-8500
http://www.daxor.com

SectorHealthcare
IndustryMedical Instruments & Supplies
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Michael Richard FeldschuhChairman, Pres & CEO1N/A1969
Mr. Jonathan Adam FeldschuhChief Scientific Officer & Director41.85kN/A1965
Mr. Robert J. Michel CPAChief Financial OfficerN/AN/A1957
Ms. Kathryn A. KornafelVP of Marketing & Commercial Devel.N/AN/AN/A
Mr. Guido ManzoVP of SalesN/AN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Daxor Corporation, a medical device company, provides biotechnology and cryobanking services in the United States. The company offers BVA-100 Blood Volume Analyzer, an instrument that measures blood volume in human body. BVA-100 Blood Volume Analyzer is used to diagnose and treat patients in various medical and surgical conditions, including congestive heart failure, critical care medicine and intensive care unit medicine, hypertension, syncope, pre-operative blood screening for hidden anemia, anemia in cancer patients, kidney failure, and hyponatremia. It also provides semen banking, blood storage, andrology, and general lab testing services. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was founded in 1970 and is headquartered in New York, New York.

Corporate Governance

Daxor Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.